Key Takeaways
- Record year, confident guide: FY26 delivered highest-ever PAT, EBITDA and revenue; management expects 10–15% revenue growth in FY27, with gross margins holding around 35%.
- Gross margin surge: Gross margins expanded 750 bps YoY to 37.3% in Q4, driven by better pricing and demand, though management declined to strip out the Forex impact on the call.
- Registration engine is the moat, but pace is unpredictable: The 3,011 active registrations plus 1,004 in the pipeline create limited competition and pricing power, yet bureaucratic delays make the timing of new approvals impossible to forecast.
- Working capital tightened sharply: Working capital days improved by 20 days to 98 days, reflecting what management calls well-controlled inventory after the industry-wide overstocking episode of 2022.
- What to watch next quarter: Whether the 10–15% revenue growth guidance holds once volume and price assumptions are separated, and whether the registration pipeline converts at the optimistic pace management expects.
The Registration Moat
- Registrations are the barrier to entry: Each product registration is expensive, time-consuming and requires repeated field trials, which management argues makes the business unattractive to most investors and limits competition.
- Pipeline is large but timing is opaque: 1,004 applications are in process globally, and management is optimistic about receiving many approvals in FY27, but concedes that authorities change requirements, field trials depend on weather, and meetings are irregular.
- Growth does not hinge solely on new molecules: Older products continue to be used, and agricultural demand rises with population; management estimates roughly 30% of revenue now comes from products launched in the last 3–4 years.
- Market share runway is vast: With less than 5% global market share, even a one-point gain to 6% would represent a roughly 20% increase in business, and management sees customer relationships and reliability as the primary growth levers.
Bubna: "My always statement that we are a marketing company. And for this marketing, registration is the most important and very strong requirement to market the products. And we are not doing trading that buying a few kilograms here and there and selling and all that."
FY27 Guidance & Underlying Assumptions
- Top-line growth of 10–15%: Management describes this as an impression that can change, with volume growth expected around 15%, implying a potential realization decline that management declined to comment on.
- Gross margin target around 35%: Expected to stay in a similar range to Q4 FY26, plus or minus a few percent, with the caveat that Forex movements are not under management control.
- EBITDA margin of 18–20%: Management expects to maintain healthy margins in this band, supported by the ability to pass through 80–90% of raw material price increases to customers.
- Effective tax rate of 18–20%: Reflects the mix of different tax rates across the global jurisdictions where Sharda operates.
- Europe and LATAM as volume drivers: Similar growth expected in Europe next year, with LATAM also contributing to volume expansion.
- Non-agro segment growing modestly: The conveyor belt business is expected to grow 5–10%, with margins having improved due to better demand and pricing in a made-to-order model.
Bubna: "Normally, we are able to pass because the competition is limited. We are not dealing with products which are freely tradable and registration process is very expensive and time consuming and not very interesting to most of the investors."
Margin & Cost Structure
- Gross margin expanded 600 bps for the full year to 35.9%: Q4 hit 37.3%, driven by better demand and improved pricing across the portfolio.
- Forex loss is unrealized and point-in-time: The INR 26 cr Forex loss in Q4 reflects realignment of foreign currency payables at the quarter-end exchange rate and does not indicate the full-year trend.
- Management declined to isolate the Forex effect on gross margins: When asked to calculate gross margins stripping out Forex movement, management said it was not prepared to do so on the call but offered to follow up via investor relations.
- Raw material pass-through is structural, not guaranteed: While 80–90% of increases have historically been passed on, the mechanism relies on limited competition from the registration moat; a shift in competitive dynamics could weaken this.
Working Capital & Inventory
- Working capital days improved by 20 days to 98: Management attributes this to disciplined inventory management and the resolution of the industry-wide overstocking that followed COVID-era scarcity fears.
- Inventory is under control: Management states the situation is well managed, distancing Sharda from the 2022 episode where many market players over-ordered and created excess pipeline inventory.
- The 2022 write-off was industry-driven, not company-specific: Sharda faced the consequences of market-wide behavior but did not contribute to the cause, per management.
Bubna: "It was not any step done by an individual company like Sharda Cropchem. We were only facing the situation, but we were not having any contribution to the cause of the situation."
Regional & Segment Dynamics
- NAFTA agrochemical revenue declined 6%: No specific cause was identified; management pointed to possible weather conditions and economic situations in the United States.
- Ukraine business continues despite war: Goods are transported to European ports and picked up by Ukrainian trucks; orders and payments are received on time, and the company has supplied Ukraine for five years without interruption.
- Non-agro segment grew only 1% for the full year: When pressed on the weak performance, management deflected the question and moved to the next analyst in the queue.
- Sales returns were dismissed as immaterial: Management declined to provide full-year sales return figures, stating they were not significant enough to have the information ready.
Bubna: "We continued, we have been supplying our goods to Ukraine for the last 5 years, even now. They are buying from us, their ports have been destroyed, the goods are getting transported to European ports and from European ports, the trucks come from Ukraine and pick up the goods."
Management's Engagement with Detail
- Guidance is impressionistic, not modeled: When asked for the detailed calculations behind the 10–15% revenue growth guidance, management said it had not done them and described the figure as an impression that can change.
- Volume-versus-realization tension was not resolved: An analyst noted that 15% volume growth plus 10–15% revenue growth implies a drop in realization; management declined to comment.
- Product concentration data was not provided: When asked whether the contribution of the top 5–10 products had remained in the same range, management said only that it keeps going up and down.
- Off-patent opportunity was not quantified: Asked about products going off patent in the next 2–3 years, management described the general process without giving a specific pipeline or sizing.
- Slowing registration additions were not directly addressed: When an analyst asked how to view the business given slowing registration additions, management used a food analogy and emphasized that older products continue to sell, without engaging the trend.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 10% to 15% growth, described as an impression that can change | FY27 |
| Gross margin | Around 35%, plus or minus a few percent | FY27 |
| EBITDA margin | 18% to 20% range | FY27 |
| Effective tax rate | 18% to 20% | FY27 |
| Volume growth | Around 15% | FY27 |
| Non-agro segment growth | 5% to 10% | FY27 |
| Registration approvals | Optimistic about receiving a good amount, but timing is unpredictable due to bureaucratic uncertainties | FY27 (no specific date) |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue | ₹2,065 cr, +13% YoY |
| Agrochemical revenue | ₹1,927 cr, +14% YoY |
| Non-agrochemical revenue | ₹138 cr, +0.3% YoY |
| Volume growth | +4.3% YoY; forex impact +11.7%, price and product mix -3.0% |
| Gross margin | 37.3%, +750 bps YoY |
| EBITDA | ₹513 cr, +75% YoY; margin 24.8% |
| PAT | ₹319 cr, +57% YoY |
| FY27 revenue growth guidance | 10% to 15% |
| FY27 gross margin guidance | ~35%, plus or minus a few percent |
| FY27 EBITDA margin guidance | 18% to 20% |
| Working capital days | 98 days, improved by 20 days vs March 2025 |
| Total product registrations | 3,011 as on 31st March 2026; 1,004 applications in pipeline |
| Cash and bank liquid investments | ₹702 cr as on 31st March 2026; debt-free |
| Dividend per share (FY26) | ₹15, comprising ₹6 interim and ₹9 final |